Risk reduction with clopidogrel in the management of peripheral arterial disease

Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far...

Descripción completa

Detalles Bibliográficos
Autores principales: R Nayak, Keshav, J Cavendish, Jeffrey
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293969/
https://www.ncbi.nlm.nih.gov/pubmed/17703636
_version_ 1782152535134437376
author R Nayak, Keshav
J Cavendish, Jeffrey
author_facet R Nayak, Keshav
J Cavendish, Jeffrey
author_sort R Nayak, Keshav
collection PubMed
description Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far less import is given to its diagnosis and treatment. In this review, we highlight principal diagnostic and therapeutic considerations in the management of PAD and its complications. We particularly emphasize the role of clopidogrel in the reduction of risks associated with PAD.
format Text
id pubmed-2293969
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-22939692008-04-22 Risk reduction with clopidogrel in the management of peripheral arterial disease R Nayak, Keshav J Cavendish, Jeffrey Vasc Health Risk Manag Review Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far less import is given to its diagnosis and treatment. In this review, we highlight principal diagnostic and therapeutic considerations in the management of PAD and its complications. We particularly emphasize the role of clopidogrel in the reduction of risks associated with PAD. Dove Medical Press 2007-06 2007-06 /pmc/articles/PMC2293969/ /pubmed/17703636 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Review
R Nayak, Keshav
J Cavendish, Jeffrey
Risk reduction with clopidogrel in the management of peripheral arterial disease
title Risk reduction with clopidogrel in the management of peripheral arterial disease
title_full Risk reduction with clopidogrel in the management of peripheral arterial disease
title_fullStr Risk reduction with clopidogrel in the management of peripheral arterial disease
title_full_unstemmed Risk reduction with clopidogrel in the management of peripheral arterial disease
title_short Risk reduction with clopidogrel in the management of peripheral arterial disease
title_sort risk reduction with clopidogrel in the management of peripheral arterial disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293969/
https://www.ncbi.nlm.nih.gov/pubmed/17703636
work_keys_str_mv AT rnayakkeshav riskreductionwithclopidogrelinthemanagementofperipheralarterialdisease
AT jcavendishjeffrey riskreductionwithclopidogrelinthemanagementofperipheralarterialdisease

Ejemplares similares